PuSH - Publication Server of Helmholtz Zentrum München

Zhou, L.* ; Deng, J.* ; Stenton, S. ; Zhou, J.* ; Li, H.* ; Chen, C.* ; Prokisch, H. ; Fang, F.*

Case Report: Rapid treatment of uridine-responsive epileptic encephalopathy caused by CAD deficiency.

Front. Pharmacol. 11:608737 (2020)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
We present two unrelated Chinese patients with CAD deficiency manifesting with a triad of infantile-onset psychomotor developmental delay with regression, drug-refractory epilepsy, and anaemia with anisopoikilocytosis. Timely translation into uridine supplementation, within 2-months of disease onset, allowed us to stop conventional anti-epileptic drugs and led to dramatic improvement in the clinical symptoms, with prompt cessation of seizures, resolution of anaemia, developmental progress, and prevention of development of severe and non-reversible manifestations. The remarkable recovery and prevention of advanced disease with prompt treatment, highlights the need to act immediately upon genetic diagnosis of a treatable disease. This further reinforces CAD deficiency as a treatable neurometabolic disorder and emphasises the need for a biomarker or genetic new born screening for early identification.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Anaemia With Anisopoikilocytosis ; Cad Deficiency ; Developmental Delay ; Epilepsy ; Uridine; Pyrimidine Biosynthesis; Mutations
ISSN (print) / ISBN 1663-9812
e-ISSN 1663-9812
Quellenangaben Volume: 11, Issue: , Pages: , Article Number: 608737 Supplement: ,
Publisher Frontiers
Publishing Place Lausanne
Non-patent literature Publications
Reviewing status Peer reviewed
Grants Children's Medicine Research Project of Beijing Children's Hospital, Capital Medical University
Cultivation Fund Project of the National Natural Science Foundation in Beijing Children's Hospital, Capital Medical University
BMBF through the European network of mitochondrial disorders (GENOMIT)
Prevention and Control of Major Chronic Non-Communicable Disease
special project for capital health development